Identifying side effects of commonly used drugs in the treatment of Covid 19Covid 19 치료에 일반적으로 사용되는 약물의 부작용 식별Review Published on 2020-12-092022-09-10 Journal: Scientific Reports [Category] MERS, SARS, 임상, 치료기술, 치료법, 치료제, [키워드] addition Adverse reaction Adverse reactions Atazanavir cardiovascular system caused clinical study COVID-19 treatment drug Drug safety drug-drug interaction Drug-drug interactions drugs drugs in combination estimate experimental results experiments facilitate graph hematopoietic system heparin identifying information technology Interaction other organs Patient patients produced Side effect Side effects Treatment [DOI] 10.1038/s41598-020-78697-1 PMC 바로가기 [Article Type] Review
Cardiac troponin I in SARS-CoV-2-patients: The additional prognostic value of serial monitoringSARS-CoV-2-환자의 심장 트로포닌 I: 연속 모니터링의 추가적인 예후 가치Article Published on 2020-12-012022-09-11 Journal: Clinica chimica acta; international journal of cli [Category] MERS, SARS, 바이오마커, [키워드] 113 patient 113 patients Abbott Abbott Diagnostics Admission approach Architect Biomarkers cardiac cardiac complication Cardiac complications cardiac troponin carried Clinical management clinically consecutive patient described died disease Diseases epidemiological female FIVE five groups group heparin High-sensitivity Troponin I Hospital stay hypoxia ICU information Injury kinetic Kinetic release lithium Major male median Microbiology pandemic disease Patient plasma sample plasma samples Prognosis Prognostic value risk SARS-CoV-2 SARS-CoV-2 patient SARS-CoV-2 patients sensitive sensitivity Serial monitoring. severe hypoxia STAT troponin troponin I Variation [DOI] 10.1016/j.cca.2020.09.036 PMC 바로가기 [Article Type] Article
COVID-19 versus HIT hypercoagulabilityCOVID-19 대 HIT 과응고성Review Published on 2020-12-012022-09-12 Journal: Thrombosis research [Category] MERS, SARS, 진단, [키워드] abnormality Admission Anticoagulant available data COVID-19 COVID-19 patients death deep-vein thrombosis Disseminated intravascular coagulation distress elevated fatal COVID-19 Frequency greater hematologic heparin heparin-induced thrombocytopenia hospital hypercoagulability increased risk initial intensive care limb lymphopenia Mild Myocardial infarction observational studies Occurrence Patient patient population Perspective Prognosis progression Prothrombin time recommendation reported required respiratory complication severe respiratory illness stroke syndrome thrombocytopenia Thromboprophylaxis thrombosis thrombotic event treating COVID-19 Treatment venous von Willebrand factor [DOI] 10.1016/j.thromres.2020.08.017 PMC 바로가기 [Article Type] Review
Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on MortalityCOVID-19의 항응고: Enoxaparin, Heparin 및 Apixaban이 사망률에 미치는 영향Article Published on 2020-12-012022-09-11 Journal: Thrombosis and haemostasis [Category] SARS, 바이오마커, [키워드] 2019 48 hour 48 hours adjusted Admission age Analysis analyzed Anticoagulant Anticoagulants anticoagulation anticoagulation therapy apixaban benefit categories clinical trial cohort study Comorbidity coronavirus coronavirus disease COVID-19 D-dimer D-dimer level D-dimer levels decrease decreased mortality demonstrated disease disease severity Effect Efficacy enoxaparin entire cohort filtration rate Gender glomerular filtration rate heparin Hospitalization Illness severity IMPROVE increased mortality Increases increases in Inpatients intensive care intensive care unit admission intention-to-treat Logistic regression Logistic regression analyses Mortality no increase Odds ratio oxygen oxygen saturation parameters Patient patients with moderate Prophylactic prothrombotic significant decrease stratified survival therapy Ventilation [DOI] 10.1055/s-0040-1720978 PMC 바로가기 [Article Type] Article
Anticoagulant approach in COVID-19 patients with cerebral venous thrombosisComment Published on 2020-12-012023-07-12 Journal: Journal of stroke and cerebrovascular diseases : t [Category] SARS, [키워드] Anticoagulant Cerebral venous thrombosis COVID-19 heparin [DOI] 10.1016/j.jstrokecerebrovasdis.2020.105222 PMC 바로가기 [Article Type] Comment
A low dose heparinized saline protocol is associated with improved duration of arterial line patency in critically ill COVID-19 patients저용량 헤파린화 식염수 프로토콜은 중환자의 동맥관 개통 기간 개선과 관련이 있습니다.Observational Study Published on 2020-12-012022-08-31 Journal: Journal of critical care [Category] MERS, 임상, 치료제, [키워드] age arterial line assessment baseline characteristics bleeding bleeding risk Characteristics clinically Cohort cohorts Complication coronavirus disease Coronavirus disease 2019 Coronavirus disease 2019 (COVID-19) COVID-19 COVID-19 patient COVID-19 patients Critical illness Critically ill Critically ill patient critically ill patients Efficacy episode episode of failure groups heparin ICU incidence low dose material median Observational cohort study Patient protocol risk significantly systemic anticoagulation thrombosis Vascular access Vascular access devices Vascular access devices. with COVID-19 [DOI] 10.1016/j.jcrc.2020.08.025 PMC 바로가기 [Article Type] Observational Study
Thromboprofilaxys With Fondaparinux vs. Enoxaparin in Hospitalized COVID-19 Patients: A Multicenter Italian Observational StudyMedicine Published on 2020-11-272022-10-31 Journal: Frontiers in Medicine [Category] COVID-19, [키워드] acute respiratory distress acute respiratory distress syndrome anticoagulant therapy bleeding event Clinical characteristics clinical impact Clinical prognosis clinically COVID-19 COVID-19 patient COVID-19 patients cumulative death decreased mortality Deep venous thrombosis drug Effectiveness Efficacy enoxaparin enrolled evaluate event Evidence FIVE Follow-up fondaparinux heparin hospital Hospitalized hospitalized COVID-19 patients hospitalized patient incidence incidence rate interquartile Italian Laboratory major bleeding major bleedings median multicenter observation outcome pharmacological Prophylaxis Prospective Study provide Pulmonary embolism Regression model retrospective risk Safe setting severe coronavirus disease shown significant difference significant differences statistically significant difference symptomatic patient syndrome therapy Thromboprofylaxis Thromboprophylaxis two group Venous Thromboembolism VTE [DOI] 10.3389/fmed.2020.569567 PMC 바로가기 [Article Type] Medicine
D-Dimer, Fibrinogen, and IL-6 in COVID-19 Patients with Suspected Venous Thromboembolism: A Narrative Review정맥 혈전 색전증이 의심되는 COVID-19 환자의 D-이량체, 피브리노겐 및 IL-6: 내러티브 검토Review Published on 2020-11-132022-09-10 Journal: Vascular Health and Risk Management [Category] MERS, 바이오마커, [키워드] activated acute respiratory distress acute respiratory distress syndrome acute respiratory syndrome acute respiratory syndrome coronavirus aPTT ARDS China Coagulation Coagulopathy coronavirus coronavirus disease Coronavirus disease 2019 cough COVID-19 COVID-19 patient COVID-19 patients critical COVID-19 patient critical COVID-19 patients Critically ill critically ill patients Cytokine storm D-dimer D-dimers Deep vein Deep vein thrombosis Degradation develop Disease progression Disseminated intravascular coagulation District DVT early diagnosis elevated Evidence evidence of Fever FIBRIN fibrin degradation products fibrinogen Fibrinogen levels global pandemic Health Organization heparin highlighting hyperactivity IL-6 include interleukin interleukin-6 intravascular coagulation Laboratory parameters lethargy LMWH low molecular weight low molecular weight heparin manifestation Mortality multiple organ failure narrative Organ failure Platelets Prognostic factor Prophylaxis prothrombin Prothrombin time Pulmonary embolism reducing respiratory respiratory distress review risk SARS-CoV-2 Seafood severe acute respiratory syndrome Coronavirus shown stages Suspected syndrome THROMBOPLASTIN Thromboprophylaxis thrombosis Thrombosis prophylaxis thrombotic thrombotic event Thrombotic events Treatment upper respiratory symptom upper respiratory symptoms Venous Thromboembolism VTE West WHO World Health Organization [DOI] 10.2147/VHRM.S280962 PMC 바로가기 [Article Type] Review
Heparin-Induced Thrombocytopenia in Severe COVID-19Article Published on 2020-11-102023-06-19 Journal: Circulation [Category] Fulltext, SARS, [키워드] COVID-19 heparin thrombocytopenia [DOI] 10.1161/CIRCULATIONAHA.120.049015 PMC 바로가기
Inhaled and systemic heparin as a repurposed direct antiviral drug for prevention and treatment of COVID-19Article Published on 2020-11-012023-07-12 Journal: Clinical medicine (London, England) [Category] SARS, [키워드] COVID-19 heparin inhalation pulmonary coagulation. SARS-CoV-2 [DOI] 10.7861/clinmed.2020-0351 PMC 바로가기